Eli Lilly has entered a definitive agreement to acquire obesity drugmaker Versanis for $1.93 billion — a move that will boost Eli Lilly’s weight loss drug treatment portfolio.
Read the full post on Becker's Hospital Review - Healthcare News
Eli Lilly to buy weight loss drugmaker for $1.93B
